⌘K
t
Polarean Imaging Plc announced its audited final results for the year ended 31 December 2022, reporting net cash of US$16.4 million and United States Food and Drug Administration (FDA) approval for its XENOVIEW drug device combination product on 23 December 2022, along with two cleared 510(k) devices. The company also announced the appointment of Frank Schulkes, Dan Brague, and Marcella Ruddy as independent Non-Executive Directors, and Ken West as Non-Executive Chairman, while scheduling its Annual General Meeting for 28 June 2023.
| Date | 26 May 2023 |
| Time | 07:00:05 |
| Category | Results |
| ID | 7366A |